Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine for PONV in Strabismus Surgery
NCT04054479Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of penehyclidine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 48 hours. Started Jul 2019; status: completed.
02
Drugs
penehyclidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04054479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054479.